These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 607955)

  • 1. [Coronary artery spasm induced in humans by ergonovine maleate].
    Specchia G; Valsecchi O; De Servi S; Bramucci E; Gavazzi A
    Boll Soc Ital Biol Sper; 1977 Sep; 53(17):1452-8. PubMed ID: 607955
    [No Abstract]   [Full Text] [Related]  

  • 2. The provocation of coronary artery spasm.
    Chahine RA
    Cathet Cardiovasc Diagn; 1980; 6(1):1-5. PubMed ID: 6988081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coronary spasm and the ergonovine test. Clinical applications].
    Crittin J; Waters DD; Théroux P; Mizgala HF
    Arch Mal Coeur Vaiss; 1980 Aug; 73(8):913-7. PubMed ID: 6774680
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of coronary blood flow during coronary artery spasm occurring spontaneously and after provocation by ergonovine maleate.
    Ricci DR; Orlick AE; Doherty PW; Cipriano PR; Harrison DC
    Circulation; 1978 Feb; 57(2):392-5. PubMed ID: 618632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiographic effect of ergonovine and nifedipine in coronary artery spasm.
    Rich S; Ford LE; Al-Sadir J
    Circulation; 1980 Nov; 62(5):1127-30. PubMed ID: 7418165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications after provocation of coronary spasm with ergonovine maleate.
    Bauman D
    Am J Cardiol; 1978 Oct; 42(4):694-5. PubMed ID: 696655
    [No Abstract]   [Full Text] [Related]  

  • 7. [The local and systemic effects of intracoronary ergonovine in patients with normal and nonspastic coronary arteries. A comparison with the intravenous ergonovine test].
    Fournier JA; Cortacero JA; Hernández Aparicio MC; Granado C; Vallejo J
    Rev Esp Cardiol; 1991; 44(6):383-8. PubMed ID: 1924954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of ergonovine on coronary artery diameter and hemodynamics in patients with angina pectoris at rest (author's transl)].
    Bussmann WD; Klug W; Scriba U; Kaltenbach M
    Z Kardiol; 1980 Jul; 69(7):478-87. PubMed ID: 6778005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased basal tone and hyperresponsiveness to acetylcholine and ergonovine in spasm-related coronary arteries in patients with variant angina.
    Lee SJ; Park SJ; Park SW; Kim JJ; Song JK; Hong MK; Kang DH; Cheong SS
    Int J Cardiol; 1996 Jul; 55(2):117-26. PubMed ID: 8842780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ergonovine test in angina with normal coronary arteries. Is it worth doing it?
    Coma-Canella I; Castano S; Macías A; Calabuig J; Artaiz M
    Int J Cardiol; 2006 Feb; 107(2):200-6. PubMed ID: 16412797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The provocation of coronary spasm in man by ergonovine maleate. Angiographic demonstration (author's transl)].
    Guglielmo LD; Montemartini C; Bobba P; Specchia G; Angoli L; Deservi S; Mussini A; Marinoni GP
    Ann Radiol (Paris); 1976 Oct; 19(6):583-6. PubMed ID: 827967
    [No Abstract]   [Full Text] [Related]  

  • 12. [Risks of the ergonovine maleate test in triggering coronary spasm].
    Schurtz C; Lesbre JP; Kalisa A; Fry P; Courbert MT
    Nouv Presse Med; 1980 May; 9(20):1448. PubMed ID: 7383867
    [No Abstract]   [Full Text] [Related]  

  • 13. [Coronary artery tone assessed by the administration of ergonovine maleate and nitrates].
    Hoshio A; Takami T; Fujimoto Y; Yamasaki J; Hasegawa J; Kotake H; Mashiba H
    J Cardiol; 1988 Dec; 18(4):989-96. PubMed ID: 3267736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged coronary vasoconstrictor effect of ergonovine maleate.
    Kurnik PB; Spadaro JJ; Nordlicht SM; Tiefenbrunn AJ; Ludbrook PA
    Cathet Cardiovasc Diagn; 1984; 10(4):353-61. PubMed ID: 6435881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of ketanserin on ergonovine-induced contractions of isolated canine coronary arteries.
    Van Beek J; Janssen PA; Van Nueten JM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):167-71. PubMed ID: 6651401
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of ergonovine maleate on coronary arterial size.
    Cipriano PR; Guthaner DF; Orlick AE; Ricci DR; Wexler L; Silverman JF
    Circulation; 1979 Jan; 59(1):82-9. PubMed ID: 758127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective hypercontraction caused by ergonovine in the canine coronary artery under conditions of induced atherosclerosis.
    Kawachi Y; Tomoike H; Maruoka Y; Kikuchi Y; Araki H; Ishii Y; Tanaka K; Nakamura M
    Circulation; 1984 Feb; 69(2):441-50. PubMed ID: 6690109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reproducibility of the clinical, electrocardiographic and coronarographic aspects of spontaneous coronary spasm with the use of ergonovine maleate].
    Bramucci E; Specchia G; De Servi S; Angoli L; Mussini A; Marinoni GP; Gavazzi A; Falcone C; Valsecchi O; Montemartini C
    G Ital Cardiol; 1978 May; 8(5):489-95. PubMed ID: 669106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ischemic cardiopathy with patent epicardial coronary arteries. Vasomotricity of the arterioles of the heart].
    Ribeiro Jorge PA; de Camargo AM
    Arq Bras Cardiol; 1987 Jul; 49(1):9-14. PubMed ID: 3450259
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of lidoflazine on contractions of isolated canine coronary arteries caused by norepinephrine, 5-hydroxytryptamine, high potassium, anoxia and ergonovine maleate.
    Van Neuten JM; Van Beek J; Vanhoutte PM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):179-87. PubMed ID: 7359366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.